Drug intelligence / Profile preview

Liangxue Huayu Fang

Development stage: Unknown
Lead developer: Shanghai Hospital of Integrated Traditional Chinese and Western Medicine
Administration: Oral

Overview

Liangxue Huayu Fang is a Traditional Chinese Medicine (TCM) herbal formula developed by the Shanghai Hospital of Integrated Traditional Chinese and Western Medicine. It is designed based on the TCM principles of "cooling the blood" (Liangxue) and "resolving blood stasis" (Huayu), targeting the underlying damp-heat and blood-heat syndromes common in inflammatory skin conditions. The formula is typically administered as oral granules. It is currently being investigated in clinical research as an add-on therapy for the treatment of cutaneous vasculitis, specifically in patients presenting with TCM damp-heat syndrome, to evaluate its efficacy in reducing skin lesions and preventing recurrence.

Other names: Liangxue Huayu FormulaLiangxue Huayu Decoction

Beyond the preview

Go deeper on Liangxue Huayu Fang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liangxue Huayu Fang.

Explore the full profile